These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 15831200

  • 1. Tumour targeting: biological factors and formulation advances in injectable lipid nanoparticles.
    Shenoy VS, Vijay IK, Murthy RS.
    J Pharm Pharmacol; 2005 Apr; 57(4):411-22. PubMed ID: 15831200
    [Abstract] [Full Text] [Related]

  • 2. Solid lipid nanoparticles as drug delivery systems.
    Manjunath K, Reddy JS, Venkateswarlu V.
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465
    [Abstract] [Full Text] [Related]

  • 3. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
    Malam Y, Loizidou M, Seifalian AM.
    Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
    [Abstract] [Full Text] [Related]

  • 4. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP, Chaubal MV, Shorr R.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):757-67. PubMed ID: 18096269
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug.
    Hamad I, Moghimi SM.
    Expert Opin Drug Deliv; 2008 Feb 17; 5(2):205-19. PubMed ID: 18248319
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):768-77. PubMed ID: 18077051
    [Abstract] [Full Text] [Related]

  • 10. pH-sensitive liposomes--principle and application in cancer therapy.
    Karanth H, Murthy RS.
    J Pharm Pharmacol; 2007 Apr 17; 59(4):469-83. PubMed ID: 17430630
    [Abstract] [Full Text] [Related]

  • 11. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.
    Saito R, Krauze MT, Noble CO, Tamas M, Drummond DC, Kirpotin DB, Berger MS, Park JW, Bankiewicz KS.
    J Neurosci Methods; 2006 Jun 30; 154(1-2):225-32. PubMed ID: 16472868
    [Abstract] [Full Text] [Related]

  • 12. Chapter 6 - Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery.
    Souto EB, Doktorovová S.
    Methods Enzymol; 2009 Jun 30; 464():105-29. PubMed ID: 19903552
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nanoparticle and targeted systems for cancer therapy.
    Brannon-Peppas L, Blanchette JO.
    Adv Drug Deliv Rev; 2004 Sep 22; 56(11):1649-59. PubMed ID: 15350294
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nano- or submicron-sized liposomes as carriers for drug delivery.
    Fang JY.
    Chang Gung Med J; 2006 Sep 22; 29(4):358-62. PubMed ID: 17051832
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Drug penetration in solid tumours.
    Minchinton AI, Tannock IF.
    Nat Rev Cancer; 2006 Aug 22; 6(8):583-92. PubMed ID: 16862189
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.